Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-19

Clinical Trial Update: An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial assessing efficacy and safety of oral contraceptives containing norgestimate or desogestrel for acne, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ethinyl estradiol/desogestrel (ethinyl estradiol + desogestrel)
  • Ethinyl estradiol/norgestimate (ethinyl estradiol + norgestimate)

Snippet

Sponsor: Janssen-Cilag Ltd.,Thailand | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2013-06-19